88 results about "Human breast milk" patented technology

The present invention is an improved valve system for a naturally shaped and hands-free human breast milk collection device that fits into a mother's existing nursing or standard brassiere. The invention comprises a submersible valve system within a breast milk collection device, which can significantly increase the breast milk collection capacity of the device without increasing the overall size of the device.

An air circuit is disclosed that communicates with a cycling, bi-directional or intermittent pressure source, splitting the output of the pressure source into two channels. One channel continues to cycle bi-directional or intermittent pressure, and a second channel employs a one-way valve allowing output of vacuum only. In one embodiment, this circuit can be used to actuate unidirectional, pulsating human breast milk expression devices that use vacuum to draw milk, while massaging the breast with pulsating pressure. The air circuit preferably includes an additional one-way valve, which is located upstream of the one-way negative pressure valve, for relief of excess positive pressure within the circuit. The negative channel output of the air circuit can contain a pressure regulation apparatus for end-user control of negative pressure to the expression devices.

A breast shield for a breast pump for expressing human breast milk, comprising a funnel for applying to the human mother's breast and a connection part, wherein the funnel widens in the direction of the mother's breast and encloses at least one nipple and one areola surrounding the nipple of the mother's breast. The funnel comprises an end near to the breast, which forms a contact edge for contacting the mother's breast. The breast shield has a through-opening which extends from the end of the funnel near the breast up to the end of the connection part further from the breast, and which serves to apply a negative pressure to the mother's breast and to discharge expressed breast milk. The contact edge of the funnel is formed by a space curve that is not positioned in one plane, wherein the funnel has at least two planes of symmetry. The breast shield permits an application on the mother's breast that is optimally sealing and comfortable for the mother.

A service system in the field of collecting human breast milk or in the field of medical drainage has a base unit assigned to an individual or an entity and at least one mobile data medium. The mobile data medium can be brought by a user into data-communicating connection on the one hand with products in the field and on the other hand with the base unit. The base unit can be brought by the user into communicating connection with an external information and data platform. The system according to the invention offers optimal care and support of users in the field.

The present disclosure relates generally to a composition for feeding an infant. More particularly, the disclosure relates to a nutritional composition for feeding an infant comprising a stem-cell deficient first component and a second component comprising breast milk stem cells (BSCs). The second component is added to the first component, and the BSCs partially or fully replenish the stem-cell deficient first component with respect to BSCs. In some embodiments the first component is stem-cell deficient human breast milk and the second component comprises BSCs from the infant's mother's own milk. The compositions of the present disclosure have been developed primarily as a personalized, nutritional composition providing the beneficial effects of an infant's mother's own BSCs to the infant while not being able to receive the full benefits of being breastfed directly.The present disclosure also relates to a composition for feeding an infant and to processes of their production. In particular, the disclosure relates to a composition for feeding an infant comprising a first and a second component, wherein the first component provides the majority of the nutritional value to said composition, and wherein the second component comprises at least one live bacterium from human breast milk or the lactating human mammary gland. The disclosure has been developed primarily as a composition for feeding a mother's own infant, wherein the composition comprises processed human breast milk with a substantially reduced live bacterial cell count as compared to unprocessed breast milk but which at least one live bacterium, from the mother's own breast milk, is added such as to partially or fully replenish the processed human breast milk with respect to the at least one live bacterium. More particular, the composition is a personalised composition for feeding the mother's own preterm infant.The present invention also related to the combination of BSC and bacterial replenishment as described herein.

The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide for promoting or inducing a global gut microbiota that is closer to the one of infants fed exclusively with human breast milk, in comparison to infants fed with a conventional nutritional composition. The composition can be an infant formula and is in particular intended for infants between 0 and 12 months of age fed predominantly with infant formula. It promotes a healthy intestinal flora and has beneficial short and long terms effects.

The invention relates to a breast shield unit for use together with a breast pump for expressing human breast milk, comprising a breast shield (2) for receiving a mother's breast (B) and a media separating device (7, 9) for exerting a vacuum in the interior of the breast shield (2). Said breast shield (2) has a receiving area (33) for receiving a nipple of the mother's breast (B). The media separating device (7, 9) has a media separating diaphragm (9) which can be moved to and fro between two positions for the purpose of transmitting the vacuum. The media separating diaphragm (9) is located in the receiving area (33), at least in one of the two aforementioned positions. The breast shield unit according to the invention can be produced extremely compactly, despite integrated media separation, and minimizes the dead volume.

A breast pump for pumping human breast milk has a flexible pumping membrane and a stiff cap, which can be fitted onto said pumping membrane, this resulting in the formation of a pumping chamber for generating a negative pressure. The cap can be, or is, connected to a breast-shield unit via a suction line. The pumping membrane has an encircling collar with a step and a laterally projecting protrusion. The cap has, on its inner side, an encircling abutment region and also at least one form-fitting element, which is spaced apart from the encircling abutment region and establishes a form fit with the protrusion of the pumping membrane. The cap is positioned with a snap fit on the pumping membrane. In the abutment region (53), it establishes a joint frictional fit with a step of the pumping membrane and thus forms a seal. The snap-fit positioning of the cap on the pumping membrane is sufficient for the cap to be retained with sealing action on the pumping membrane.

The invention discloses application of a set of miRNAs in preparation of a marker for screening early-stage breast cancers. The invention discovers that free miRNAs with completeness and relative abundance quite accordant with mammary gland cells exist in human breast milk for the first time. Through comparison with abnormal miRNAs which are abnormally expressed by the breast cancers and are confirmed by existing researches, a set of breast milk free miRNAs suitable for potential application of the screening of the early-stage breast cancers are analyzed, 26 miRNAs are expected to be regulatedup in the development process of the early-stage breast cancers, and 12 miRNAs are expected to be regulated down in the development process of the early-stage breast cancers. The invention disclosesa theoretically feasible application detection scheme. By taking breast milk as a sample, the affection risk of the early-stage breast cancers is detected by detecting free miRNA markers related withthe breast cancers in the breast milk.

The present invention relates to a liquid milk fortifier composition for administration to infants, which fortifier composition comprises lipids in an amount of above 75% of the caloric content. The fortifier may be administrated to infants either as a supplement to human breast milk or to infant formulas. The present invention also relates to the use of the fortifier composition as well as a kit of parts for use in providing a lipid and / or calorie adapted body weight dependent nutrition to infants.

The invention relates to an adapter (2) for a breast shield (1) of a breast pump for pumping human breast milk. Said adapter has a chamber (280) having a first opening (282) leading to the breast shield (1) and a second opening (283) remote from the breast shield. The adapter (2) also has a flexible media separation membrane (4), which is accommodated in the chamber (280) and separates the chamber (280) into a pump-side and a breast-shield-side area. The chamber (280) tapers toward the breast-shield-side opening (282). The chamber (280) has the shape of a spherical dome which is cut off in the tapering area thereof. The media separation membrane (4) likewise has substantially the shape of a flattened spherical dome having a flat top side (411), wherein the flat top side (411) of the media separation membrane (4) faces the breast-shield-side opening (202) of the chamber (280). The adapter according to the invention permits a minimum pressure drop over the media separation membrane and ensures a reliable return to the original shape of the media separation membrane.

Disclosed herein are infant supplements containing casein, a salt of casein, whey and / or a casein hydrolysate which are free of carbohydrate, and methods for their use with breast feeding babies. The supplements are designed to suppress serum bilirubin levels and the incidence and severity of neonate jaundice. In one form, a dose of such a supplement is mixed with human breast milk and fed to the neonate.

A test kit detects presence of ethanol alcohol in human breast milk. The test kit includes an alcohol oxidase reactive in the presence of ethanol alcohol in breast milk and oxygen, an indicator having a visible color when not subjected to oxidizing agent, in sufficient amount for visible observance, and a peroxidase reactive in the presence of acetaldehyde and peroxide, to yield oxidizing agent, in sufficient amount to induce change to the visible color of the hydrogen donor indicator. The test kit is a sealed pack containing a test strip. The test strip is for one-time use, and disposable after testing. The test strip is handled by a tester, typically a breast-feeding mother. The mother contacts her breast milk lactate with testing portion of the test strip. The testing portion selectively reacts to alcohol, and not other components of breast milk. A reactive agent of the testing portion of the test strip changes color in the presence of alcohol. The mother observes the result to determine if there is presence of alcohol in the breast milk.

The invention relates to a nutritional composition for infants and young children, such as an infant formula or follow-on formula or growing up milk, preferably an infant formula, and comprising a fatty acid derivative or mixtures thereof, for example ARA and / or DHA. The a fatty acid derivative or a mixture thereof, for example ARA and / or DHA promotes and / or supports an ideal myelination trajectory in the brain, such trajectory being close to that observed in infants fed exclusively with human breast milk (HBM). The infants or young children can be between 0 and 60 months, preferably between 0 and 12 months of age.

Disclosed herein are infant dietary supplements containing L-aspartic and / or L-malic acid. The supplements are designed to inhibit beta-glucuronidase activity in breast feeding babies, and thereby suppress serum bilirubin levels and the incidence of neonate jaundice. In one form L-aspartic acid is mixed with human breast milk and fed to the neonate on the same schedule that breast feeding would otherwise normally occur. In another form the L-aspartic acid is delivered in an aqueous solution supplemented with sodium and potassium.